Updated Date: Wed, 01 Jul 2020 00:00:00 EDT

Merck, Eisai’s Keytruda-Lenvima combo stonewalled in liver cancer after Roche’s first-in-class green light aliu Wed, 07/08/2020 – 09:16

AstraZeneca, Lilly, Sanofi and others raise prices to start July: report esagonowsky Wed, 07/08/2020 – 09:38

Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint arlene.weintraub Wed, 07/08/2020 […]

AbbVie draws first blood in trade secrets war between Allergan’s Botox and Evolus kblankenship Wed, 07/08/2020 – 10:53

Mylan recalls lot of injectable daptomycin after particulates show up in vial fkansteiner Wed, 07/08/2020 – 11:12

“For the first half of my career I was looking after people’s physical and mental health, and now […]

The drug is the only PARP inhibitor approved in this disease

Phase I clinical testing scheduled to begin mid-July

AGILE is a ‘proof of confidence engine’ designed to quickly identify the most promising compounds for treatment of […]